161 related articles for article (PubMed ID: 16574683)
1. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
[TBL] [Abstract][Full Text] [Related]
2. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
[TBL] [Abstract][Full Text] [Related]
4. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
[TBL] [Abstract][Full Text] [Related]
5. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
[TBL] [Abstract][Full Text] [Related]
8. A case of Gitelman's syndrome with decreased angiotensin II-forming activity.
Eto K; Onaka U; Tsuchihashi T; Hirano T; Nakayama M; Masutani K; Hirakata H; Urata H; Yasujima M
Hypertens Res; 2006 Jul; 29(7):545-9. PubMed ID: 17044667
[TBL] [Abstract][Full Text] [Related]
9. The search for a link between inflammation and hypertension--contribution from Bartter's/Gitelman's syndromes.
Pagnin E; Davis PA; Semplicini A; Calò LA
Nephrol Dial Transplant; 2006 Aug; 21(8):2340-2. PubMed ID: 16611677
[No Abstract] [Full Text] [Related]
10. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
[TBL] [Abstract][Full Text] [Related]
11. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling.
Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC; Calò LA
J Hypertens; 2004 Oct; 22(10):1963-9. PubMed ID: 15361768
[TBL] [Abstract][Full Text] [Related]
12. [Effects of angiotensin II on inflammation mediators in healthy subjects].
Lottermoser K; Ulrich-Merzenich G; Vetter H; Düsing R
Dtsch Med Wochenschr; 2003 Nov; 128(47):2470-5. PubMed ID: 14628252
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein and intercellular adhesion molecule-1 are stronger predictors of oxidant stress than blood pressure in established hypertension.
Cottone S; Mulè G; Nardi E; Vadalà A; Lorito MC; Guarneri M; Arsena R; Palermo A; Cerasola G
J Hypertens; 2007 Feb; 25(2):423-8. PubMed ID: 17211250
[TBL] [Abstract][Full Text] [Related]
14. Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity.
Calò L; Davis PA; Milani M; Cantaro S; Antonello A; Favaro S; D'Angelo A
Clin Nephrol; 1999 Jan; 51(1):12-7. PubMed ID: 9988141
[TBL] [Abstract][Full Text] [Related]
15. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
[TBL] [Abstract][Full Text] [Related]
16. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension.
Cottone S; Mulè G; Nardi E; Vadalà A; Guarneri M; Briolotta C; Arsena R; Palermo A; Riccobene R; Cerasola G
Am J Hypertens; 2006 Mar; 19(3):313-8. PubMed ID: 16500520
[TBL] [Abstract][Full Text] [Related]
17. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
[TBL] [Abstract][Full Text] [Related]
18. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
[TBL] [Abstract][Full Text] [Related]
19. Biglycan expression in hypertensive subjects with normal or increased carotid intima-media wall thickness.
Sardo MA; Mandraffino G; Campo S; Saitta C; Bitto A; Alibrandi A; Riggio S; Imbalzano E; Saitta A
Clin Chim Acta; 2009 Aug; 406(1-2):89-93. PubMed ID: 19523462
[TBL] [Abstract][Full Text] [Related]
20. Are the Clinical Presentations (Phenotypes) of Gitelman's and Bartter's Syndromes Gene Mutations Driven by Their Effects on Intracellular pH, Their "pH" Enotype?
Calò LA; Davis PA
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32784543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
